STRUCTURAL OUTCOMES IN THE SACROILIAC JOINT AFTER IXEKIZUMAB TREATMENT FOR 16 WEEKS IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY GENDER, HLA-B27, AND BASELINE MRI INFLAMMATION

被引：1
|
作者：
Maksymowych, W. P. [1 ]
Baraliakos, X. [2 ]
Lambert, R. G. [3 ]
Landewe, R. B. M. [4 ]
Sandoval, D. [5 ]
Carlier, H. [6 ]
Lisse, J. [5 ]
Li, X. [5 ]
Hojnik, M. [5 ]
Ostergaard, M. [7 ,8 ]
机构：
[1] Univ Alberta, Div Rheumatol, Dept Med, Edmonton, AB, Canada
[2] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, Herne, Germany
[3] Univ Alberta, Dept Radiol & Diagnost Imaging, Edmonton, AB, Canada
[4] Amsterdam Rheumatol & Immunol Ctr, Dept Clin Immunol & Rheumatol, Amsterdam, Netherlands
[5] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN USA
[6] Eli Lilly & Co, Immunol Med, Brussels, Belgium
[7] Rigshospitalet, Copenhagen Ctr Arthrit Res, Ctr Rheumatol & Spine Dis, Glostrup, Denmark
[8] Univ Copenhagen, Dept Clin Med, Glostrup, Denmark
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2322
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0301
引用
收藏
页码：399 / 399
页数：1
相关论文
共 32 条
  • [21] Prevalence and HLA-B27 Positivity Rate among Patients with Ankylosing Spondylitis/Non-Radiographic Axial Spondyloarthritis in Japan
    Matsubara, Yuri
    Nakamura, Yosikazu
    Tomita, Tetsuya
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50
  • [22] Efficacy of Ixekizumab on Disease Activity and Quality of Life in Patients with Active Nonradiographic Axial Spondyloarthritis and Objective Signs of Inflammation, Stratified by Baseline CRP/Sacroiliac Joint MRI Status
    Maksymowych, Walter
    Marzo-Ortega, Helena
    Ostergaard, Mikkel
    Gensler, Lianne
    Ermann, Joerg
    Deodhar, Atul
    Poddubnyy, Denis
    Sandoval, David
    Bolce, Rebecca
    Kronbergs, Andris
    Liu-Leage, Soyi
    Doridot, Gabriel
    Geneus, Vladimir
    Leung, Ann
    Adams, David
    Rudwaleit, Martin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [23] Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status
    Rudwaleit, Martin
    Deodhar, Atul
    Bauer, Lars
    Gensler, Lianne
    Hoepken, Bengt
    Kumke, Thomas
    Auteri, Simone Emanuele
    Kim, Mindy
    Maksymowych, Walter
    RMD OPEN, 2024, 10 (02):
  • [24] Quality of Life in Patients with Active Non Radiographic Axial Spondyloarthritis After 16 Weeks of Golimumab Treatment
    Maksymowych, Walter
    Curtis, Sean
    Dougados, Maxime
    Bergman, Gina
    Huyck, Susan
    Tzontcheva, Anjela
    Sieper, Joachim
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1179 - 1180
  • [25] LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS
    Zochling, Jane
    Robinson, Philip C.
    Maksymowych, Walter P.
    Gensler, Lianne S.
    Rudwaleit, Martin
    Hoepken, Bengt
    Bauer, Lars
    Kumke, Thomas
    Kim, Mindy
    Deodhar, Atul
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 25 - 25
  • [26] Long-Term Clinical Outcomes of Certolizumab Pegol Treatment in Patients with Active Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status
    Robinson, Philip C.
    Maksymowych, Walter P.
    Gensler, Lianne
    Rudwaleit, Martin
    Hoepken, Bengt
    Bauer, Lars
    Kumke, Thomas
    Kim, Mindy
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 808 - 810
  • [27] LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS
    Robinson, P.
    Maksymowych, W. P.
    Gensler, L. S.
    Rudwaleit, M.
    Hoepken, B.
    Bauer, L.
    Kumke, T.
    Kim, M.
    Deodhar, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 774 - 775
  • [28] Active and Structural Lesions on MRI of the Sacroiliac Joints Predict Major Clinical Responses in Patients with Non-Radiographic Axial Spondyloarthritis Treated with Etanercept.
    Maksymowych, W. P.
    Wichuk, S.
    Jones, H.
    Szumski, A.
    Marshall, L.
    Bukowski, J.
    Lambert, R. G.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S378 - S378
  • [29] GENETIC (HLA B27), ENVIRONMENTAL (SMOKING) AND INFLAMMATORY (MRI POSITIVITY) FACTORS ARE INDEPENDENT PREDICTORS OF RADIOGRAPHIC PROGRESSION OF THE SACROILIAC JOINTS IN EARLY AXIAL NON-RADIOGRAPHIC SPONDYLOARTHRITIS
    Dougados, M.
    Demattei, C.
    van den Berg, R.
    Hoang, V. V.
    Thevenin, F.
    Reijnierse, M.
    Loeuille, D.
    Feydy, A.
    Claudepierre, P.
    van der Heijde, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 757 - 757
  • [30] HLA-B27 STATUS IS ASSOCIATED WITH TNFα INHIBITOR TREATMENT OUTCOMES IN ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS OBSERVATIONAL COHORT STUDY FROM THE NATIONWIDE DANBIO REGISTRY
    Glintborg, B.
    Sorensen, I. Juul
    Ostergaard, M.
    Mahamoud, A. A.
    Krogh, N. S.
    Andersen, L. S.
    Raun, J. L.
    Hendricks, O.
    Kowalski, M. R.
    Danielsen, L.
    Christensen, S. R.
    al Chaer, N.
    Pelck, R.
    Nordin, H.
    Pedersen, J. K.
    Kraus, D. G. A.
    Hansen, I. M. Jensen
    Espesen, J.
    Schlemmer, A.
    Loft, A. G.
    Salomonsen, L.
    Dreyer, L.
    Hetland, M. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 801 - 801
1234